BlackRock
SANA icon

BlackRock’s Sana Biotechnology SANA Stock Holding History

BlackRock’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.2M Buy
16,675,173
+2,434,998
+17% +$7.84M ﹤0.01% 2586
2026
Q1 		$41M Buy
14,240,175
+16,648
+0.1% +$65.6K ﹤0.01% 2634
2025
Q4 		$57.9M Buy
14,223,527
+2,997,391
+27% +$13.4M ﹤0.01% 2433
2025
Q3 		$39.9M Buy
11,226,136
+367,236
+3% +$1.33M ﹤0.01% 2644
2025
Q2 		$29.6M Sell
10,858,900
-600,840
-5% -$1.24M ﹤0.01% 2794
2025
Q1 		$19.3M Sell
11,459,740
-473,336
-4% -$1.32M ﹤0.01% 2963
2024
Q4 		$19.5M Buy
11,933,076
+115,781
+1% +$345K ﹤0.01% 3069
2024
Q3 		$49.2M Buy
11,817,295
+771,847
+7% +$4.05M ﹤0.01% 2481
2024
Q2 		$60.3M Buy
11,045,448
+1,999,304
+22% +$15.9M ﹤0.01% 2310
2024
Q1 		$90.5M Buy
9,046,144
+576,922
+7% +$4.32M ﹤0.01% 2107
2023
Q4 		$34.6M Buy
8,469,222
+475,259
+6% +$1.75M ﹤0.01% 2710
2023
Q3 		$30.9M Buy
7,993,963
+109,186
+1% +$587K ﹤0.01% 2685
2023
Q2 		$47M Buy
7,884,777
+82,950
+1% +$478K ﹤0.01% 2523
2023
Q1 		$25.5M Buy
7,801,827
+16,476
+0.2% +$65.8K ﹤0.01% 2845
2022
Q4 		$30.8M Buy
7,785,351
+824,894
+12% +$4.03M ﹤0.01% 2787
2022
Q3 		$41.8M Sell
6,960,457
-34,872
-0.5% -$252K ﹤0.01% 2583
2022
Q2 		$45M Buy
6,995,329
+524,453
+8% +$3.34M ﹤0.01% 2564
2022
Q1 		$53.5M Buy
6,470,876
+500,173
+8% +$4.04M ﹤0.01% 2547
2021
Q4 		$92.4M Buy
5,970,703
+872,033
+17% +$16.8M ﹤0.01% 2263
2021
Q3 		$115M Buy
5,098,670
+3,283,779
+181% +$68.9M ﹤0.01% 2126
2021
Q2 		$35.7M Buy
1,814,891
+35,575
+2% +$806K ﹤0.01% 2925
2021
Q1 		$59.6M Buy
+1,779,316
New +$57.9M ﹤0.01% 2512

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock's SANA Position: Q2 2026 in Review

BlackRock increased its Sana Biotechnology (SANA) stake by 17% in Q2 2026, buying an estimated $7.84M and bringing the position to 16,675,173 shares worth $58.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

BlackRock first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $115M in Q3 2021. 210 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • BlackRock held 16,675,173 shares of Sana Biotechnology worth $58.2M as of Q2 2026.
  • BlackRock bought 2,434,998 Sana Biotechnology shares in Q2 2026, an estimated $7.84M.
  • Sana Biotechnology made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2586 holding.
  • BlackRock first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • BlackRock's Sana Biotechnology position peaked at $115M in Q3 2021.
  • 210 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.